Table 2 Impact of patient and surgical characteristics on development of postoperative MACE
| Â | MACE | Â | |
|---|---|---|---|
|  | Absent (n = 476) | Present (n = 32) | P value |
Age, ≥ 75 years | 163 (34) | 12 (38) | 0.704 |
Sex, male | 378 (79) | 21 (66) | 0.076 |
BMI, ≥ 25 kg/m2 | 147 (31) | 12 (38) | 0.436 |
Smoking history | 294 (62) | 19 (59) | 0.852 |
NYHA class, III or IV | 40 (8) | 13 (41) |  < 0.001 |
Hypertension | 394 (83) | 24 (75) | 0.336 |
Dyslipidemia | 380 (80) | 23 (72) | 0.267 |
Diabetes mellitus | 285 (60) | 22 (69) | 0.356 |
Lung disease | 33 (7) | 2 (6) |  > 0.999 |
Malignancy | 11 (2) | 1 (3) | 0.546 |
Atrial fibrillation | 40 (8) | 3 (9) | 0.745 |
ESRD | 47 (10) | 7 (22) | 0.066 |
Stroke | 98 (21) | 5 (16) | 0.651 |
Preoperative beta blocker use | 300 (63) | 14 (44) | 0.038 |
Preoperative statin use | 331 (70) | 19 (59) | 0.240 |
Hemoglobin, < 10 g/dL | 104 (22) | 9 (28) | 0.387 |
LVEF, < 40% | 38 (8) | 6 (19) | 0.048 |
Moderate/severe MR | 13 (3) | 2 (6) | 0.242 |
Emergency surgery | 13 (3) | 7 (22) |  < 0.001 |
Presence of anastomosis LCX | 366 (77) | 23 (72) | 0.520 |
Operative time, ≥ 4 h | 117 (25) | 9 (28) | 0.674 |
IABP use | 199 (42) | 22 (69) | 0.005 |
Blood loss, > 2000 mL | 22 (5) | 2 (6) | 0.657 |